Advanced Endometrial Cancer: Treatment Optimization - Episode 5

Common Adverse Events Seen With Chemotherapy for Advanced Endometrial Cancer

December 7, 2022

Courtney R. Arn, APRN-CNP, Kimberly Halla, NP, Kathleen Lutz, RN, NP-BC WH, Kimberly A. Spickes, CNP

Continuing her discussion, Kathleen highlights the most common adverse events she sees in patients treated with chemotherapy for advanced endometrial cancer who are unfit for surgery.

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

EP. 1: Patient Profile Presentation: A 76-Year-Old Woman With Advanced Endometrial Cancer

EP. 2: Fertility and Other Treatment Considerations for Patients With Advanced Endometrial Cancer

EP. 3: Currently Available Treatment Modalities in Endometrial Cancer

EP. 4: First-Line Treatments for Patients With Advanced Endometrial Cancer Who Are Unfit for Surgery

Now Viewing

EP. 5: Common Adverse Events Seen With Chemotherapy for Advanced Endometrial Cancer

EP. 6: Efficacy of Chemotherapy in Patients with Advanced Endometrial Cancer

EP. 7: Treatment Options for Patients with Recurrent Endometrial Cancer

EP. 8: Educating Patients With Endometrial Cancer on Treatment-Related Adverse Events

EP. 9: Monitoring Patients on Therapy for Recurrent Endometrial Cancer

EP. 10: Adverse Events Seen With Combination Lenvatinib and Pembrolizumab for Recurrent Endometrial Cancer

EP. 11: Proactive Adverse Effect Management for Patients on Therapy for Endometrial Cancer

EP. 12: Discussing Dose Reductions and Interruptions with Patients on Therapy for Endometrial Cancer

EP. 13: Greatest Unmet Needs for Patients with Endometrial Cancer

EP. 14: Advice for New Nurse Practitioners Working With Patients With Endometrial Cancer